At the end of the 1960's, lymphonodo-venous anastomosis has been performed by Olszewski and Nielubowicz experimentally as well as in clinical cases. Later on, various authors performed in clinical cases microsurgical anastomoses between lymphcollectors and veins. The rationality of this procedure is based on the knowledge that lymph always find the way back to the venous system, that the pressure of the lymph vessels is higher than in venous system of the extremities and that competent valves guarantee a centripetal flow. Beginning in the middle of the 1980's, we performed microsurgical end-to-end lympho-venous anastomoses in invagination technique for the treatment of secondary arm lymphoedema. The operation can be performed in local anesthesia, the anastomoses are performed on the proximal lower arm and on the medial portion of the upper arm. In each localisation three to four lympho-venous anastomoses are performed. Not only subjectively there is a decrease of the complaints but also variable reduction of the volume of the edematous arms can be achieved. In average the volume-reduction reaches 30 %. Data of a follow-up of 53 patients up to ten years show stable results. This is a long-standing benefit and supports further conservative therapy as manual lymphdrainage. Nevertheless lymphoedema is a chronical and irreversible disease which cannot be definitively cured with operative or with conservative procedures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-2003-42129 | DOI Listing |
Br J Dermatol
January 2025
Centre of Evidence Based Dermatology, School of Medicine, Faculty of Medicine & Health Sciences, University of Nottingham, UK.
Background: Randomised controlled trials (RCTs) evaluating new systemic treatments for atopic dermatitis (AD) have increased dramatically over the last decade. These trials often incorporate topical therapies either as permitted concomitant or rescue treatments. Differential use of these topicals post-randomisation introduces potential bias as they may nullify or exaggerate treatment responses.
View Article and Find Full Text PDFObes Surg
January 2025
Zuyderland Medisch Centrum, Sittard, Netherlands.
Background: The ring-augmented Roux-en-Y gastric bypass (raRYGB) has been reported to result in higher long-term weight loss compared to regular Roux-en-Y gastric bypass (RYGB). However, the type of ring used varied within studies, leading to heterogeneity in reported results. Therefore, this study compares the 5-year results of RYGB with and without ring augmentation using a specific prefabricated gastric ring.
View Article and Find Full Text PDFClin Exp Metastasis
January 2025
Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Oligorecurrent prostate cancer (PCa) can be treated with metastasis-directed therapy (MDT), which may be performed using radioguided surgery (RGS) as an experimental approach. These procedures have shown promising outcomes, largely due to the high lesion detection rate of positron emission tomography/computed tomography (PET/CT). We present a case series of patients who underwent RGS following robot-assisted radical prostatectomy (RARP).
View Article and Find Full Text PDFPediatr Nephrol
January 2025
Division of Molecular Medicine, University of São Paulo School of Medicine, São Paulo, Brazil.
Predicting the risks of progression to chronic kidney disease (CKD) stage 5 in idiopathic nephrotic syndrome (NS) and recurrence of the disease (rNS) following kidney transplantation (KT) is a key assessment to provide essential management information. NS has been categorized etiologically as genetic and immune-based. A genetic cause can be identified in ~ 30% of children with steroid-resistant NS (SRNS), a finding associated with a very low risk of rNS following KT.
View Article and Find Full Text PDFInt Urogynecol J
January 2025
Biogipuzkoa Health Research Institute, Donostia/San Sebastián, Spain.
Introduction And Hypothesis: Stress urinary incontinence (SUI) is a highly prevalent condition in women. We hypothesized that the Tampsec™ vaginal tampon will be efficacious and well tolerated in its treatment.
Methods: This was a multicenter open-label parallel-group randomized control trial.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!